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Two different hematocrit detection methods: Different methods,
different results?
Abstract
BACKGROUND: Less is known about the influence of hematocrit detection methodology on
transfusion triggers. Therefore, the aim of the present study was to compare two different
hematocrit-assessing methods. In a total of 50 critically ill patients hematocrit was analyzed using (1)
blood gas analyzer (ABLflex 800) and (2) the central laboratory method (ADVIA(R) 2120) and
compared. FINDINGS: Bland-Altman analysis for repeated measurements showed a good correlation
with a bias of +1.39% and 2 SD of +/- 3.12%. The 24%-hematocrit-group showed a correlation of r2 =
0.87. With a kappa of 0.56, 22.7% of the cases would have been transfused differently. In
the-28%-hematocrit group with a similar correlation (r2 = 0.8) and a kappa of 0.58, 21% of the cases
would have been transfused differently. CONCLUSIONS: Despite a good agreement between the two
methods used to determine hematocrit in clinical routine, the calculated difference of 1.4% might
substantially influence transfusion triggers depending on the employed method.
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Abstract
Background: Less is known about the influence of hematocrit detection methodology on transfusion triggers. 
Therefore, the aim of the present study was to compare two different hematocrit-assessing methods. In a total of 50 
critically ill patients hematocrit was analyzed using (1) blood gas analyzer (ABLflex 800) and (2) the central laboratory 
method (ADVIA® 2120) and compared.
Findings: Bland-Altman analysis for repeated measurements showed a good correlation with a bias of +1.39% and 2 
SD of ± 3.12%. The 24%-hematocrit-group showed a correlation of r2 = 0.87. With a kappa of 0.56, 22.7% of the cases 
would have been transfused differently. In the-28%-hematocrit group with a similar correlation (r2 = 0.8) and a kappa of 
0.58, 21% of the cases would have been transfused differently.
Conclusions: Despite a good agreement between the two methods used to determine hematocrit in clinical routine, 
the calculated difference of 1.4% might substantially influence transfusion triggers depending on the employed 
method.
Findings
Measurement of hemoglobin or hematocrit is of major 
importance in contemporary patient care. Anemia or 
traumatic/surgical blood loss might require transfusion 
of red blood cells (RBC) to increase oxygen delivery and 
counteract tissue hypoxia. However, clear transfusion 
triggers are difficult to define because there is no clear 
delineation between risk and benefit. To date, at least 3 
large randomized controlled trials have compared restric-
tive transfusion triggers to a more liberal transfusion 
regime in critically ill adult patients[1], pediatric inten-
sive care patients[2] and premature infants [3]. All three 
studies showed that a restrictive transfusion regime 
reduced RBC transfusion requirements without increas-
ing morbidity and mortality. In this context, hemoglobin 
concentrations ranging from 7-9 g/dl were compared to 
10-12 g/dl.
In this context, we have observed a discrepancy between 
the hematocrit values determined by routine arterial 
blood gas analysis compared to routine analysis in our 
central laboratory. Therefore, we analyzed 250 blood 
samples taken from 50 critically ill patients. The aims 
were (1) to compare two different hematocrit-testing 
methods routinely used in our intensive care unit (ICU) 
and hospital (central laboratory) and (2) to determine 
whether these two methods might provide different 
transfusion triggers.
In accordance with the principles outlined by the World 
Medical Association declaration of Helsinki and follow-
ing approval by the local Ethics Committee which waived 
the need for written informed consent for this post hoc 
data analysis, patient data from 50 patients treated on our 
intensive care unit from November 2007 to March 2008 
were analyzed retrospectively. A total of 50 critically ill 
patients treated consecutively in our department were 
included irrespective of hemodynamic stability or diag-
nosis for the comparison of the two methods.
Blood was drawn daily, usually, at 6 a.m. for routine labo-
ratory analysis, including 2 hematograms performed with 
2 different methods. To compare hematocrit values 
determined by these two different methods of analysis, 
250 paired hematocrit values (data of 50 patients over 5 
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Page 2 of 6consecutive days resulting in 250 paired samples) were 
considered. The patients were assigned to 2 different 
groups depending on the transfusion targets set during 
ICU treatment. A total of 20 patients with severe trau-
matic brain injury, severe burns, following reconstructive 
surgery or with cardiac ischemia had a hematocrit target 
of 28%. The other 30 patients had a target hematocrit of 
24%.
On the ICU arterial blood samples were routinely drawn 
in 4 to 6 hour intervals to control paO2, paCO2, hemat-
ocrit, glucose or potassium serum levels, required to 
optimize ventilatory settings, guide transfusions, and 
adapt intravenous infusion of insulin or potassium. These 
blood samples were analysed by the nurses using the 
commercially available blood gas analyzer ABLflex 800 
(Radiometer Medical, Copenhagen, Denmark; http://
www.Radiometer.com) located on our ICU. Blood was 
drawn daily, usually, at 6 a.m. for routine laboratory anal-
ysis. Among others, differential blood count including 
analysis of hemoglobin/hematocrit was performed. As a 
standardized pre- analytic procedure[4,5], at least 2 ml of 
blood were discarded to prevent hemodilution by infused 
fluids before withdrawing blood for the actual analysis 
using specialized syringes, i.e., the syringe for the 
ABLflex 800 (Arterial Blood sampler 1.7 ml, Radiometer 
Copenhagen, Denmark) and vacutainers (BD Vacutainer® 
K2E 5.4 mg, BD-Plymouth, PL67BP, UK) for the ADVIA 
2120.
Method 1: ABLflex 800
The specimen is drawn from the syringe into the cuvette 
within the gas analyzer maintained at 37°C. Thereafter, 
one microliter of the specimen is hemolized via ultra-
sound (30 kHz). Hemoglobin content is assessed spectro-
photometrically using 128 different wave lengths (478 to 
672 nm). The light is transmitted via glass-fiber optics 
through a diffraction gating, which diffracts the light into 
128 single wavelengths. The detecting device consists of 
128 photo diodes. According to the equation of Lambert-
Beer hemoglobin content (ctHb) of the blood sample is 
determined. Based on the ctHb the hematocrit (hct) is 
calculated via an internal algorithm.
Method 2: ADVIA 2120
(Siemens Medical Solutions Diagnostics, Zurich, Switzer-
land, http://www.diagnostics.siemens.com): This device 
uses 2 sequential methods of haemoglobin measurement:
(1) Flow cytometry: In a first step red blood cells are 
applied to iso-volumetric sphering and partial fixa-
tion. Then a second reagent encases the sample 
stream and the entire specimen passes through a flow 
cell. A red laser then measured cell volume and intra-
cellular haemoglobin concentration. The amount of 
light scattered at low angle (2-3°) is dependent on the 
cell volume and the high angle (5-15°) is related to the 
refractive index of the cell, reflecting the haemoglobin 
concentration for red blood cells (CHCM). The hae-
matocrit then is calculated.
(2) A cyanide-free reagent (borate solution) and a sur-
factant (N, N,-dimethyllaurylamine N-oxide) cause 
haemolysis and facilitate the oxidation of haeme iron 
to Fe 3+. Because of the alkaline pH of the reagent 
haemoglobin loses most of its salt bridges. The ligated 
heme groups are solubilized by surfactant micelles to 
generate a green end-product which can be detected 
photometrically[6].
During analysis both values for haemoglobin determined 
by 1 and 2 are compared by an internal algorithm. In case 
of a predefined discrepancy the haemoglobin value is cor-
rected in respect to the colorimetric method which is 
considered as the "gold standard" [7].
Our null hypothesis was that the two different methods 
(ABLflex 800 and ADVIA 2120) were equal and did not 
provide different transfusion triggers. The alternative 
hypothesis was that the ABLflex 800 method is not equal 
to the ADVIA 2120 method.
Bland-Altman analysis corrected for repeated measure-
ments [8,9] and Cohen's kappa statistics [10] were used to 
compare the two methods (Statview 4.5, abacus concepts, 
Berkeley, CA, USA). Cohen's kappa statistics compares 
the observations of two different methods and therefore 
results in 4 possible cases: +/+, +/-, -/+ and -/-. There is 
an agreement of the methods in the cases of +/+ and -/- 
(i.e. "transfused"/"transfused" and "not transfused"/"not 
transfused") and there is no agreement in the cases +/- 
and -/+ (i.e.,"transfused"/"not transfused" and "not trans-
fused"/"transfused"), respectively. With kappa ≤ 0.4 the 
agreement is poor, if kappa is between 0.4 and 0.75 agree-
ment is fair and kappa ≥ 0.75 reflects excellent agreement 
between these two methods.
Comparisons between groups were calculated either with 
Chi-square test, with a nonparametric Mann-Whitney 
test or ANOVA log rank test (Statview 4.5, abacus con-
cepts, Berkeley, CA, USA). Statistical significance level 
was accepted with p < 0.05.
The investigated 50 patients were grouped according to 
the pre- defined transfusion triggers (24 and 28%) used 
on our intensive care unit for different illnesses, resulting 
in 30 patients within the 24-%-hematocrit-group and 20 
patients in the 28-%-hematocrit-group. As depicted in 
table 1 these two hematocrit target groups consist of het-
erogeneous patients with different leading diagnosis 
which, in turn, dictated different treatment concepts and 
different transfusion triggers. Consequently, these 2 
groups are not comparable. Serum levels of lactate and 
body temperature were significantly different in the 2 
groups (p = 0.02 and 0.04, respectively). Hospital mortal-
ity was also significantly different (p = 0.03).
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patients showed a good agreement with a bias of +1.39% 
and 2 standard deviations (2 SD) of ± 3.12% (figure 1). 
Thus, the ABL800 flex method showed an approximately 
1.4% higher hematocrit than the ADVIA 2120 method. 
Bias for each group was not statistically different (1.11 ± 
1.83% in the 24%-hematocrit-group vs. 1.70 ± 1.24% in 
the 28%-hematocrit-group, p = 0.26).
According to the targeted transfusion triggers of 24% and 
28% two kappa statistical analysis were performed in 30 
patients with a transfusion trigger set at hematocrit of 
24% and 20 patients with a hematocrit transfusion trigger 
Table 1: Baseline and clinical characteristics
Parameter 24%-hct-group 28%-hct-group p-value
Number of patients 30 20
Men 21 (70%) 15 (75%) 0.70
Women 9 (30%) 5 (25%) 0.70
Age (yrs.) 52.5 ± 13.6 44.8 ± 28 0.17
Heart rate (bpm) 94 ± 24 83 ± 22 0.07
MAP (mmHg) 76 ± 15 83 ± 11 0.11
Weight (kg) 87.2 ± 34.7 70.8 ± 11.4 0.10
Height (cm) 172 ± 10 174 ± 10 0.70
Diagnosis
Sepsis 11 (36.7%) 0
Lung-TPL 3 (10%) 0
Liver-TPL 2 (6.7%) 0
Fascitis 1 (3.3%) 0
Mesothelioma 1 (3.3%) 0
Liver Cirrosis 1 (3.3%) 0
Colon-Carcinoma 1 (3.3%) 0
Severe Brain injury 0 9 (45%)
Polytrauma 8 (26.7%) 2 (10%)
Severe burn injury 0 8 (40%)
ARDS 1 (3.3%) 0
Gastric bypass 1 (3.3%) 0
Cardiac arrest 0 1 (5%)
Lactat (mmol/l) 1.7 ± 1.8 1.2 ± 0.7 0.02
Temp. (°C) 37.0 ± 1.5 36.7 ± 1.3 0.04
Blood glucose
(mmol/l)
6.7 ± 1.3 6.7 ± 1.9 0.15
Norepinephrine
(microg/min)
7.9 ± 11.5 8.3 ± 12.8 0.10
SAPS II 39 ± 17 31 ± 15 0.07
Hospital mortality 15 (50%) 4 (20%) 0.03
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Page 4 of 6of 28%. In those patients with a predefined hematocrit 
target of 24% (n = 150 values) both methods showed a 
significant correlation of r2 = 0.87 (figure 2). Kappa of 
0.56 indicated a fairly good agreement of the methods, 
i.e., values located within the lower field below 24% 
(square III) reflect patients who needed to be transfused 
according to both methods of analysis and square I 
depicts those patients in whom transfusions were not 
required, regardless of analytical procedure. In contrast, 
square II shows 34 patients (22.7%) who would have been 
transfused according to the hematocrit values deter-
mined by the central laboratory. According to the blood 
gas analysis, however, these patients would not have been 
transfused.
In patients with predefined hematocrit target of 28% (n = 
100 values) both methods also correlated well with r2 = 
0.8 (figure 3). Kappa of 0.58 also reflected a fairly good 
agreement of these two methods, i.e., values located 
within square III below 28% reflected patients requiring 
RBC transfusions according to both methods of analysis. 
Square II shows 21 patients (21%) in whom hematocrit 
determined by the central laboratory would have sug-
gested RBC transfusion while blood gas analysis would 
not have indicated RBC transfusion. In square I none of 
the patients would be transfused, regardless of analytical 
procedure.
According to the present analysis, ADVIA 2120 and 
ABLflex 800 provide similar hematocrit values. Never-
theless, values close to the lower transfusion/hematocrit 
threshold will be strongly influenced by the employed 
analytical method. Thus, these methodological differ-
ences must be considered in addition to the defined 
transfusion trigger to standardize transfusion practice 
within the individual ICU/hospital and across different 
Figure 2 In 30 patients with a predefined hematocrit target of 
24% (n = 150 values) both methods showed a significant correla-
tion of r2 = 0.87 and kappa was 0.56, indicating a fair agreement 
of the methods. Values located within the lower field below 24% 
(square III) reflect patients who need to be transfused according to 
both methods of analysis; in contrast, square II shows 34 patients 
(22.7%) who would have been transfused according to the hematocrit 
values determined by the central laboratory.
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Figure 3 In 20 patients with predefined hematocrit target of 28% 
(n = 100 values) both methods correlated well with r2 = 0.8, a kap-
pa of 0.58 reflected a fair agreement of the methods. Values locat-
ed within square III below 28% reflect patients who require RBC 
transfusions according to both methods of analysis, whereas square II 
shows 21 patients (21%) in whom hematocrit determined by the cen-
tral laboratory would have suggested RBC transfusion while blood gas 
analysis would not have indicated RBC transfusion.
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Figure 1 Bland-Altman analysis for repeated measurements of all 
patients showed a good agreement with a bias of +1.39% and 2 
standard deviations (2 SD) of ± 3.12%. The lower and upper limits of 
agreement (bias ± 2 SD) are -1.73 and 4.51%, respectively. Thus, the 
ABLflex 800 method showed elevated hematocrit by approximately 
1.4%.
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Page 5 of 6hospitals in multi-center trials [1]-[3]. In this context, it is 
of critical importance to use the same analytical proce-
dure.
Analytical procedures are strongly dependent on in vivo 
and in vitro influences: In this context, the preanalytic 
phase is crucial for the subsequent analytic process[11] 
and most importantly for the interpretation of the 
obtained results. Point-of-care testing (POCT) has been 
introduced in clinical routine to provide analytical results 
more rapidly and to allow shorter therapeutic response 
intervals. For POCT systems like the ABLflex 800, prean-
alytic steps are decisive which include correct blood with-
drawal with discarding of the first sample and immediate 
analysis to prevent hemodilution and stability of the spec-
imens, respectively. Inappropriate handling and pro-
longed delay will result in sedimentation of RBC and will 
interfere with subsequent analysis. Details for preanalyt-
ics in POCT are described by Hicks et al [12]. Another 
important factor is the time span from blood withdrawal 
to their processing within the analyzer to optimize stabil-
ity of hematological analysis which is time-dependent 
and hematology analyzer dependent[13]. In our ICU the 
nursing staff is trained in standardized blood withdrawal 
and immediate blood gas analysis within minutes after 
blood collection.
The samples for the ADVIA 2120 are directly sent to the 
hematology laboratory, marked "emergency" which guar-
antees immediate processing, providing results within 
one hour. The pre-analytic process and the rest of the 
testing in the laboratory is highly standardized. Thus, 
assuming that pre-analytic errors occurred, we would 
rather have to consider this a systematic error.
The ADVIA 2120 method may be influenced by hemo-
lytic samples or lipemia leading to falsely elevated hemat-
ocrit levels, in contrast cold antibodies can decrease 
hematocrit. In addition, polyglobulia may affect the mea-
surement [14]. In our population polyglobulia or lipemia 
was not present; cold antibodies were not searched for 
routinely.
The International Committee for Standardization in 
Hematology (ICSH) recommends the cyanmethemoglo-
bin method as a reference method for hemoglobin mea-
surement[7].
Although blood gas analyzers as POCT methods are 
increasingly used to provide rapid analysis of hematocrit 
in ICU, emergency departments, and operating theaters, 
data showing reliability between the different methods is 
scarce. A Belgian multicenter study compared different 
POCT methods to standard laboratory analyzer and 
found differences from 0.6 to 4.1% [15] which was cor-
roborated by two other studies[16,17].
To date, we lack detailed studies addressing the impact of 
different analytical methods on the transfusion manage-
ment. Although both tested methods showed a fair to 
good agreement, approximately 21% of our samples 
might lead to a different transfusion management. Taken 
together, apart from clinical parameters transfusion trig-
gers must not only be defined as simple values but must 
be considered as method-dependent parameters. In the 
literature none of the landmark papers [1-3] mentioned 
the hemoglobin analyzing method. This, in turn, could in 
theory, lead to different results of these studies. Most 
importantly, multi-center trials must use the same 
method of analysis to avoid false transfusions.
Concerning the ICSH guidelines which recommend the 
cyanmethemoglobin method as a standard method, the 
ADVIA 2120 method might be more appropriate to mea-
sure hemoglobin/hematocrit. Nevertheless, transfusing 
according to the ADVIA 2120 method would increase the 
transfusion rate in our patients with its additional risks.
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